Factors | Univariate analysis | ||||
---|---|---|---|---|---|
OR | 95%CI | P | |||
Lower | Upper | ||||
Age (Years) | ≥ 44.5 vs<44.5 | 0.50 | 0.20 | 1.26 | 0.141 |
Menarche age (Years) | ≥ 13.5 vs<13.5 | 0.61 | 0.29 | 1.28 | 0.191 |
Menstrual states | Menopausal vs. Premenopausal | 0.87 | 0.37 | 2.04 | 0.743 |
Menopausal age (Years) | ≥ 51.5 vs<51.5 | 2.96 | 0.94 | 9.34 | 0.064 |
Primiparous age (Years) | ≥ 22.5 vs<22.5 | 0.60 | 0.29 | 1.28 | 0.187 |
Number of births | ≥ 3 vs<3 | 0.50 | 0.18 | 1.39 | 0.184 |
cT | 3/4 vs. 1/2 | 0.96 | 0.36 | 2.52 | 0.930 |
cN | 2/3 vs. 0/1 | 1.36 | 0.59 | 3.14 | 0.473 |
cM | 1 vs. 0 | 1.44 | 0.23 | 9.00 | 0.695 |
Axillary lymph nodes | Positive vs. Negative | 2.12 | 0.73 | 6.22 | 0.169 |
Pathological type | Other vs. IDC | 1.68E + 09 | 0.00 | 0.999 | |
Grade | 3 VS 1/2 | 2.96 | 1.09 | 8.05 | 0.033 |
ER | Positive vs. Negative | 0.44 | 0.20 | 0.95 | 0.037 |
PR | Positive vs. Negative | 0.60 | 0.28 | 1.29 | 0.194 |
HER-2 | Positive vs. Negative | 1.94 | 0.73 | 5.14 | 0.181 |
Ki-67 | ≥ 42.50 vs<42.50 | 1.96 | 0.92 | 4.20 | 0.082 |
Molecular classification | Triple negative vs. HER-2+ vs. Luminal B(HER-2+) vs. Luminal B(HER-2+) vs. Luminal A | 1.65 | 1.01 | 2.71 | 0.046 |
Therapy cycle | ≥ 7 vs<7 | 2.25 | 1.04 | 4.85 | 0.039 |
CEA (ng/mL) | ≥ 2.93 vs<2.93 | 2.29 | 0.97 | 5.39 | 0.058 |
CA153(U/mL) | ≥ 19.14 vs<19.14 | 1.57 | 0.72 | 3.40 | 0.255 |
Hb | ≥ 135.50 vs<135.50 | 0.75 | 0.36 | 1.60 | 0.463 |
WBC | ≥ 6.13 vs<6.13 | 0.41 | 0.18 | 0.95 | 0.037 |
PLT (×10^9/L) | ≥ 247.50 vs<247.50 | 2.27 | 1.04 | 4.93 | 0.038 |
LYM | ≥ 1.64 vs<1.64 | 5.92 | 2.59 | 13.55 | <0.001 |
NEU (×10^9/L) | ≥ 4.70 vs<4.70 | 0.61 | 0.29 | 1.28 | 0.189 |
Monocyte (×10^9/L) | ≥ 0.44 vs<0.44 | 0.48 | 0.20 | 1.16 | 0.102 |
ALB (g/L) | ≥ 52.15 vs<52.15 | 2.62 | 0.48 | 14.28 | 0.265 |
NLR | ≥ 2.02 vs. <2.02 | 0.13 | 0.05 | 0.34 | <0.001 |
PLR | ≥ 161.50 vs<161.50 | 0.17 | 0.08 | 0.39 | <0.001 |
LMR | ≥ 6.39 vs<6.39 | 4.34 | 1.84 | 10.26 | 0.001 |
SII | ≥ 598.50 vs<598.50 | 0.24 | 0.11 | 0.55 | 0.001 |